Deutsche Private Equity

We focus equally on scope for development, time and genuine partnerships with management.

Our News

Pharmazell: DPE invests in the generics specialist

Munich, December 16, 2013 – DPE announced today that it has acquired the majority of Zellbios Group (today Pharmazell), a globally leading manufacturer of niche, off-patent active pharmaceutical ingredients (APIs) from Ergon Capital Partners. Zellbios will continue to be led by CEO Dr. Oliver Bolzern and his management team who will also remain investors in the company. more

Medical expertise is growing with OmniaMed and DPE

Munich, July 2, 2013 – Funds advised by DPE Deutsche Private Equity GmbH (“DPE”) invest in the fast growing market for continuous medical education (CME”) by acquiring OmniaMed Group (“OmniaMed”) from US based MC Holding Corporation. more